EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Cerebrospinal fluid cell-free DNA sequencing in pediatric CNS tumors: towards liquid molecular neuropathology

William Gehin iD, Marie-Sophie Merlin, Alexandre Harle, Jean-Louis Merlin

Acta Neuropathologica · 10.08.2026 · 152 (1)

DOI: 10.1007/s00401-026-03067-6 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Neuropathologica, online erschienen am 10.08.2026. Verfasst von William Gehin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Radiotherapy, Institut de Cancérologie de Lorraine, Vandœuvre-Lès-Nancy, France. w.gehin@nancy.unicancer.fr. Hauptthemen laut MEDLINE: Central Nervous System Neoplasms, Cell-Free Nucleic Acids, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pediatric central nervous system tumors remain a leading cause of cancer-related mortality in children, while their diagnosis, risk stratification, and therapeutic management increasingly depend on integrated molecular characterization. However, representative tumor tissue is often difficult to obtain because of tumor location, surgical risk, limited biopsy material, and the impracticality of repeated sampling during disease evolution. Cerebrospinal fluid (CSF) has therefore emerged as a particularly informative liquid biopsy compartment for many CNS malignancies, enriched in tumor-derived cell-free DNA and, for tumors in contact with the CSF spaces, more directly reflective of intracranial tumor biology than plasma; its yield nonetheless varies with tumor biology and anatomical proximity to CSF pathways. Here, we review the evidence supporting CSF cell-free DNA sequencing as an emerging extension of molecular neuropathology in pediatric CNS tumors. Targeted next-generation sequencing, low-pass whole-genome sequencing, methylation-based classifiers, and nanopore sequencing now enable complementary assessment of somatic mutations, copy number alterations, epigenetic tumor class, and longitudinal tumor burden from low-input pediatric CSF samples. Recent studies have moved the field beyond analytical proof of concept towards defined clinical scenarios, including molecular diagnosis when biopsy is infeasible, molecular staging of high-CSF-shedding tumors, minimal residual disease monitoring in medulloblastoma and other embryonal tumors, and clarification of ambiguous radiological progression. CSF-based sequencing does not replace tissue neuropathology, but provides a liquid molecular layer that can complement, extend, or in selected situations partially substitute tissue-based diagnosis. Its broader adoption now depends on workflow standardization, assay-specific reporting standards, external quality assurance, and prospective evidence that CSF-guided decisions improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Nervous System NeoplasmsCell-Free Nucleic AcidsBiomarkers, TumorHumansChildLiquid BiopsyHigh-Throughput Nucleotide SequencingNeuropathology

Stichwörter der Autor:innen

Cell-free DNACerebrospinal fluidMethylation profilingMinimal residual diseaseMolecular neuropathologyNext-generation sequencingPediatric CNS tumors

Substanzen

Cell-Free Nucleic AcidsBiomarkers, Tumor

Autor:innen und Institutionen

  • Radiotherapy, Institut de Cancérologie de Lorraine, Vandœuvre-Lès-Nancy, France. w.gehin@nancy.unicancer.fr.
  • Innovative Therapeutics and Early Trials Unit, Institut de Cancérologie de Lorraine, Vandœuvre-Lès-Nancy, France. w.gehin@nancy.unicancer.fr.
  • Pediatric Oncohematology, Hôpital d'Enfants, CHRU Nancy, Vandoeuvre-Lès-Nancy, France.
  • Biopathology, Institut de Cancérologie de Lorraine, CNRS, UMR 7039 CRAN - Université de Lorraine, Vandœuvre-Lès-Nancy, France.

ORCID-Profile: William Gehin

Zitieren

APA

Gehin, W., Merlin, M. S., Harle, A., & Merlin, J. L. (2026). Cerebrospinal fluid cell-free DNA sequencing in pediatric CNS tumors: towards liquid molecular neuropathology. Acta Neuropathologica, 152(1). https://doi.org/10.1007/s00401-026-03067-6

Vancouver

Gehin W, Merlin MS, Harle A, Merlin JL. Cerebrospinal fluid cell-free DNA sequencing in pediatric CNS tumors: towards liquid molecular neuropathology. Acta Neuropathologica. 2026;152(1). doi:10.1007/s00401-026-03067-6

BibTeX
@article{Gehin2026,
  author = {Gehin, William and Merlin, Marie-Sophie and Harle, Alexandre and Merlin, Jean-Louis},
  title = {Cerebrospinal fluid cell-free DNA sequencing in pediatric CNS tumors: towards liquid molecular neuropathology},
  journal = {Acta Neuropathologica},
  year = {2026},
  volume = {152},
  number = {1},
  doi = {10.1007/s00401-026-03067-6}
}
Kostenlos starten →